AGN-19920

· Allergan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGN-19920, covering 2016-09-21 to 2016-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea [Phase 3]

See pricing